The Journal of Organic Chemistry
Article
140.6, 141.2, 146.5; IR (ATR) ν 2972, 1593, 1277, 1323, 1229, 1117,
746 cm−1; MS (EI) m/z (relative intensity, %) 416 ([M]+, 57), 194
([C14H12N]+, 100); HRMS (EI) m/z calcd for C28H24N4 (M)
416.2001, found 416.2002.
901, 828, 810, 739, 710 cm−1; MS (EI) m/z (relative intensity, %) 241
([M]+, 27), 91 ([C6H4CH3]+, 100), 119 ([N2C6H4CH3]+, 23); HRMS
(EI) m/z calcd for C13H11N3O2 (M) 241.0851, found 241.0848.
(E)-1-(3,5-Bis(trifluoromethyl)phenyl)-2-p-tolyldiazene (2bs).
Purified by silica gel column chromatography (hexane/EtOAc 99:1
to 9:1); orange solid (54.6 mg, 66%); mp 82.0−84.4 °C; Rf 0.28
Typical Procedure for the Synthesis of Asymmetric Azo
Compounds Using t-BuOI (Table 4 and 5). To a mixture of two
aromatic amines (Ar1NH2 and Ar2NH2, 0.25 mmol for each) and NaI
(1.0 mmol, 150.0 mg) in an appropriate solvent (3 mL), was added
t-BuOCl (1.0 mmol, 108.6 mg) under N2 atmosphere at the appropriate
temperature. The mixture was stirred for the indicated time and
quenched with aqueous Na2S2O3 (1.0 M, 10 mL), and the solution
was extracted with CH2Cl2 (20 mL × 3). The combined organic
extracts were dried over Na2SO4 and concentrated under vacuum to
give the crude product. Purification by flash column chromatography
on silica gel (eluent: ethyl acetate in hexane) gave cross-dimerized
product.
(E)-Ethyl 4-(p-Tolyldiazenyl)benzoate (2bi). Spectroscopic data
were in agreement with those previously reported.13d Purified by silica
gel column chromatography (hexane/EtOAc 99:1 to 7:3); yellow solid
(41.3 mg, 62%); mp 100.6−101.3 °C; Rf 0.43 (hexane/EtOAc 9:1);
1H NMR (270 MHz, CDCl3) δ 1.43 (t, 3H, J = 7.0 Hz), 2.45 (s, 3H),
4.42 (q, 2H, J = 7.0 Hz), 7.32 (d, 2H, J = 8.4 Hz), 7.87 (d, 2H, J = 8.4
Hz), 7.92 (d, 2H, J = 8.6 Hz), 8.19 (d, 2H, J = 8.6 Hz); 13C NMR
(68 MHz, CDCl3) δ 14.4, 21.6, 61.2, 122.4, 123.1, 129.7, 130.4, 131.8,
142.3, 150.6, 155.1, 165.9; IR (ATR) ν 2922, 1715, 1601, 1265, 1103,
1094, 1008, 866, 822, 773, 709 cm−1; MS (EI) m/z (relative inten-
sity, %) 268 ([M]+, 53), 91 ([C6H4CH3]+, 100), 119 ([N2C6H4CH3]+,
33), 149 ([C6H4CO2Et]+, 25); HRMS (EI) m/z calcd for C16H16N2O2
(M) 268.1212, found 268.1214.
(E)-1-(4-Acetylphenyl)-2-p-tolyldiazene (2bj). Purified by silica
gel column chromatography (hexane/EtOAc 99:1 to 7:3); red solid
(34.7 mg, 58%); mp 128.7−130.0 °C; Rf 0.18 (hexane/EtOAc 9:1);
1H NMR (270 MHz, CDCl3) δ 2.45 (s, 3H), 2.66 (s, 3H), 7.33 (d,
2H, J = 8.4 Hz), 7.86 (d, 2H, J = 8.4 Hz), 7.95 (d, 2H, J = 8.6 Hz),
8.10 (d, 2H, J = 8.6 Hz); 13C NMR (68 MHz, CDCl3) δ 21.6, 26.8,
122.7, 123.2, 129.3, 129.8, 138.1, 142.5, 150.7, 155.1, 197.5; IR (ATR) ν
1676, 1595, 1354, 1263, 1003, 962, 853, 820, 707 cm−1; MS (EI)
m/z (relative intensity, %) 238 ([M]+, 38), 91 ([C6H4CH3]+, 100),
119 ([N2C6H4CH3]+, 35); HRMS (EI) m/z calcd for C15H14N2O (M)
238.1106, found 238.1109.
1
(hexane); H NMR (270 MHz, CDCl3) δ 2.45 (s, 3H), 7.34 (d, 2H,
J = 8.1 Hz), 7.87 (d, 2H, J = 8.1 Hz), 7.95 (s, 1H), 8.33 (s, 2H); 13C
NMR (68 MHz, CDCl3) δ 21.6, 122.8 (q, J = 3.3 Hz), 123.1 (q, J =
272.9 Hz), 123.5, 130.0, 132.6 (q, J = 34.1 Hz), 143.4, 150.2, 152.9; IR
(ATR) ν 1600, 1504, 1363, 1275, 1261, 1172, 1124, 899, 828 cm−1;
MS (EI) m/z (relative intensity, %) 332 ([M]+, 31), 91 ([C6H4CH3]+,
100), 119 ([N2C6H4CH3]+, 19), 213 ([C6H4(CF3)2]+, 11); HRMS
(EI) m/z calcd for C15H10F6N2 (M) 332.0748, found 332.0745.
(E)-1-(4-Acetylphenyl)-2-phenyldiazene (2aj). Spectroscopic
data were in agreement with those previously reported.8b Purified by
silica gel column chromatography (hexane/EtOAc 99:1 to 7:3); red
solid (30.0 mg, 54%); mp 102.3−104.7 °C; Rf 0.24 (hexane/EtOAc
1
9:1); H NMR (270 MHz, CDCl3) δ 2.66 (s, 3H), 7.50−7.56 (m,
3H), 7.93−7.99 (m, 4H), 8.10 (d, 2H, J = 8.6 Hz); 13C NMR (68
MHz, CDCl3) δ 26.8, 122.8, 123.1, 129.2, 129.3, 131.7, 138.3, 152.5,
155.0, 197.4; IR (ATR) ν 2924, 1674, 1352, 1259, 961, 839, 771 cm−1;
MS (EI) m/z (relative intensity, %) 224 ([M]+, 100), 77 ([C6H5]+,
97), 105 ([N2C6H5]+, 26), 119 ([C6H4COCH3]+, 57); HRMS (EI)
m/z calcd for C14H12N2O (M) 224.0950, found 224.0952.
(E)-1-(4-Acetylphenyl)-2-(4-nitrophenyl)diazene (2jl). Spec-
troscopic data were in agreement with those previously reported.39
Purified by silica gel column chromatography (hexane/EtOAc 99:1 to
7:3); red solid (48.2 mg, 72%); mp 160.0−161.6 °C; Rf 0.15 (hexane/
1
EtOAc 9:1); H NMR (270 MHz, CDCl3) δ 2.68 (s, 3H), 8.00−8.15
(m, 6H), 8.38 (d, 2H, J = 8.4 Hz); 13C NMR (68 MHz, CDCl3) δ
26.8, 123.4, 123.7, 124.7, 129.4, 139.3, 149.1, 154.5, 155.3, 197.1; IR
(ATR) ν 1681, 1698, 1534, 1341, 1319, 1261, 1215, 1109 cm−1, 860;
MS (EI) m/z (relative intensity, %) 269 ([M]+, 68), 119 ([C6H4COCH3]+,
100), 122 ([C6H4NO2]+, 35), 147 ([N2C6H4 COCH3]+, 29); HRMS (EI)
m/z calcd for C14H11N3O3 (M) 269.0800, found 269.0803.
(E)-1-(4-Acetylphenyl)-2-(4-fluorophenyl)diazene (2ej). Puri-
fied by silica gel column chromatography (hexane/EtOAc 99:1 to
7:3); orange solid (36.8 mg, 61%); mp 111.5−114.1 °C; Rf 0.24
1
(hexane/EtOAc 9:1); H NMR (270 MHz, CDCl3) δ 2.66 (s, 3H),
7.18−7.27 (m, 2H), 7.93−8.02 (m, 4H), 8.08−8.13 (m, 2H); 13C
NMR (68 MHz, CDCl3) δ 26.8, 116.2 (d, J = 22.9 Hz), 122.8, 125.2
(d, J = 9.5 Hz), 129.3, 138.4, 149.0 (d, J = 2.8 Hz), 154.8, 164.8 (d, J =
253.3 Hz), 197.3; IR (ATR) ν 1680, 1591, 1489, 1406, 1358, 1233,
1138, 843 cm−1; MS (EI) m/z (relative intensity, %) 242 ([M]+, 62),
95 ([C6H4F]+, 100), 119 ([C6H4COCH3]+, 41), 123 ([N2C6H4F]+,
36); HRMS (EI) m/z calcd for C14H11FN2O (M) 242.0855, found
242.0855.
(E)-1-(4-Nitrophenyl)-2-p-tolyldiazene (2bl). Spectroscopic
data were in agreement with those previously reported.39 Purified by
silica gel column chromatography (hexane/EtOAc 99:1 to 7:3);
orange solid (38.5 mg, 64%); mp 180.2−181.3 °C; Rf 0.40 (hexane/
EtOAc 9:1); 1H NMR (270 MHz, CDCl3) δ 2.46 (s, 3H), 7.34 (d, 2H,
J = 8.1 Hz), 7.87 (d, 2H, J = 8.1 Hz), 7.99 (d, 2H, J = 8.9 Hz), 8.35 (d,
2H, J = 8.9 Hz); 13C NMR (68 MHz, CDCl3) δ 21.6, 123.1, 123.3,
124.5, 129.7, 143.1, 148.3, 150.4, 155.6; IR (ATR) ν 1605, 1589, 1522,
1339, 1306, 1134, 1105, 858, 826, 754 cm−1; MS (EI) m/z (relative
intensity, %) 241 ([M]+, 34), 91 ([C6H4CH3]+, 100), 119
([N2C6H4CH3]+, 25); HRMS (EI) m/z calcd for C13H11N3O2 (M)
241.0851, found 241.0847.
(E)-1-(4-Acetylphenyl)-2-(4-chlorophenyl)diazene (2fj). Puri-
fied by silica gel column chromatography (hexane/EtOAc 99:1 to
7:3); orange solid (42.0 mg, 65%); mp 149.8−152.3 °C; Rf 0.25
1
(hexane/EtOAc 9:1); H NMR (270 MHz, CDCl3) δ 2.65 (s, 3H),
7.49 (d, 2H, J = 8.6 Hz), 7.88 (d, 2H, J = 8.6 Hz), 7.94 (d, 2H, J = 8.6
Hz), 8.09 (d, 2H, J = 8.6 Hz); 13C NMR (68 MHz, CDCl3) δ 26.8,
122.9, 124.4, 129.3, 129.4, 137.7, 138.4, 150.7, 154.7, 197.3; IR (ATR) ν
1676, 1478, 1404, 1354, 1261, 1086, 1003, 852, 839 cm−1; MS (EI)
m/z (relative intensity, %) 258 ([M]+, 86), 111 ([C6H4Cl]+, 100), 119
([C6H4COMe]+, 69), 139 ([N2C6H4Cl]+, 43); HRMS (EI) m/z calcd
for C14H11ClN2O (M) 258.0560, found 258.0570.
(E)-1-(3-Chlorophenyl)-2-p-tolyldiazene (2bn). Purified by
silica gel column chromatography (hexane/EtOAc 99:1 to 7:3);
orange solid (29.3 mg, 52%); mp 104.3−105.2 °C; Rf 0.45 (hexane/
1
EtOAc 9:1); H NMR (270 MHz, CDCl3) δ 2,43 (s, 3H), 7.30−7.44
(m, 4H), 7.78−7.88 (m, 4H); 13C NMR (68 MHz, CDCl3) δ 21.5,
121.7, 122.2, 123.1, 129.8, 139.1, 130.4, 135.1, 142.2, 150.5, 153.5; IR
(ATR) ν 2924, 1728, 1599, 1454, 1260, 1070, 823, 791, 710 cm−1; MS
(EI) m/z (relative intensity, %) 230 ([M]+, 24), 91 ([C6H4CH3]+,
100), 111 ([C6H4Cl]+, 17), 119 ([N2C6H4CH3]+, 19); HRMS (EI)
m/z calcd for C13H11ClN2 (M) 230.0611, found 230.0608.
(E)-1-(3-Nitrophenyl)-2-p-tolyldiazene (2bo). Purified by silica
gel column chromatography (hexane/EtOAc 99:1 to 7:3); orange
solid (38.0 mg, 60%); mp 113.2−115.9 °C; Rf 0.38 (hexane/EtOAc
9:1); 1H NMR (270 MHz, CDCl3) δ 2.45 (s, 3H), 7.33 (d, 2H, J = 8.4
Hz), 7.67 (dd, 1H, J = 8.1, 8.1 Hz), 7.86 (d, 2H, J = 8.4 Hz), 8.21 (d,
1H, J = 8.1 Hz), 8.28 (d, 1H, J = 8.1 Hz), 8.69 (s, 1H); 13C NMR (68
MHz, CDCl3) δ 21.6, 116.9, 123.3, 124.5, 129.0, 129.8, 129.9, 143.0,
149.0, 150.3, 153.1; IR (ATR) ν 1601, 1584, 1518, 1346, 1146, 1076,
(E)-1-(4-Acetylphenyl)-2-(4-bromophenyl)diazene (2gj). Pu-
rified by silica gel column chromatography (hexane/EtOAc 99:1 to
7:3); orange solid (44.2 mg, 58%); mp 168.3−169.4 °C; Rf 0.24
1
(hexane/EtOAc 9:1); H NMR (270 MHz, CDCl3) δ 2.67 (s, 3H),
7.67 (d, 2H, J = 8.6 Hz), 7.83 (d, 2H, J = 8.6 Hz), 7.96 (d, 2H, J = 8.6
Hz), 8.10 (d, 2H, J = 8.6 Hz); 13C NMR (68 MHz, CDCl3) δ 26.8,
123.0, 124.6, 126.3, 129.4, 132.4, 138.5, 151.2, 154.7, 197.4; IR (ATR) ν
2920, 1668, 1354, 1260, 1067, 1005, 839 cm−1; MS (EI) m/z (relative
intensity, %) 302 ([M]+, 71), 119 ([C6H4COMe]+, 100), 147
([N2C6H4COMe]+, 25), 155 ([C6H4Br]+, 95), 147 ([N2C6H4Br]+, 41);
HRMS (EI) m/z calcd for C14H11BrN2O (M) 302.0055, found 302.0052.
M
dx.doi.org/10.1021/jo402120w | J. Org. Chem. XXXX, XXX, XXX−XXX